Who Makes XIFAXAN (rifaximin)?
XIFAXAN is manufactured by Salix Pharmaceuticals, Inc., a company specializing in developing and commercializing gastrointestinal medications. Salix was acquired by Bausch Health Companies Inc. in 2015, but XIFAXAN (rifaximin) remains under the Salix brand name.
XIFAXAN Manufacturer Overview
| Trade Name | XIFAXAN |
| Manufacturer | Salix Pharmaceuticals, Inc. |
| Active Ingredient | Rifaximin |
| Formula | C43H51N3O11 |
| FDA-Approval Date | May 25, 2004 |
| FDA-Approved Uses | Irritable bowel syndrome with diarrhea (IBS-D) in adults |
| Website | https://www.xifaxan.com |
What Does XIFAXAN Treat?
XIFAXAN is an antibiotic medication primarily used to treat two main conditions:
- Irritable Bowel Syndrome with Diarrhea (IBS-D): This chronic condition involves recurring episodes of diarrhea and abdominal pain. XIFAXAN is used in some cases to help manage symptoms by targeting potential bacterial overgrowth in the gut, believed to contribute to IBS-D in some individuals.
- Traveler’s diarrhea: This is a common issue often experienced by travelers visiting new regions with different bacteria present in the food and water. XIFAXAN works by targeting and eliminating specific bacteria causing diarrhea, such as E. coli.
It’s crucial to remember that XIFAXAN is a prescription medication and should only be taken under the guidance of a healthcare professional. They will determine if XIFAXAN is the appropriate treatment for your specific condition and monitor for potential side effects.
Explore More Medication Manufacturers
Now that you know more about who makes XIFAXAN, the manufacturer details, and what medical conditions it treats, you may want to compare XIFAXAN to other medication manufacturers.
Browse the medication maker guides to research popular brands and find information on a specific company.
Who’s Query is an online encyclopedia of product owners and manufacturer information that educates users about who makes popular brands.
